Apellis Pharmaceuticals, Inc. (APLS) SEC filings
APLS SEC filings moved a median of +0.02% by the close. APLS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the APLS overview →
42 measured APLS SEC filing events.
Where these APLS SEC filings landedvs 39 measured APLS SEC filing reactions
| Middle 50% of APLS SEC filing reactions | -2.39% to +3.21% |
|---|---|
| Median reaction (to close) | +0.02% |
| Measured reactions | 39 |
Point-in-time · zero look-ahead
Half of the 39 APLS SEC filing events with a measured close landed between -2.39% and +3.21%; 51% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Apellis Pharmaceuticals, | SEC filing · Form 15-12G | — | — | |
| Form 8-K Apellis Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | — | — | |
| Form S-8 POS Apellis Pharmaceuticals, | SEC filing · Form S-8 | — | — | |
| Form 10-Q Apellis Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.05% | +0.07% | |
| Form 8-K Apellis Pharmaceuticals, For: Apr 28 | SEC filing · Form 8-K | -0.01% | +0.02% | |
| Form 10-K/A Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.02% | +0.12% | |
| Form 8-K Apellis Pharmaceuticals, For: Mar 30 | SEC filing · Form 8-K | +0.03% | +0.07% | |
| Form 8-K Apellis Pharmaceuticals, For: Feb 27 | SEC filing · Form 8-K | +1.77% | +1.82% | |
| Form 10-K Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.34% | +5.78% | |
| Form S-8 Apellis Pharmaceuticals, | SEC filing · Form S-8 | -1.34% | +5.78% | |
| Form 8-K Apellis Pharmaceuticals, For: Jan 12 | SEC filing · Form 8-K | -0.92% | -6.49% | |
| Form 10-Q Apellis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.60% | -16.58% | |
| Form 10-Q Apellis Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +5.42% | +8.18% | |
| Form 8-K Apellis Pharmaceuticals, For: Jul 01 | SEC filing · Form 8-K | +0.56% | -0.17% | |
| Form 8-K Apellis Pharmaceuticals, For: Jun 03 | SEC filing · Form 8-K | -0.43% | +3.24% | |
| Form 10-Q Apellis Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -0.06% | +4.84% | |
| Form ARS Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.95% | -2.45% | |
| Form DEF 14A Apellis Pharmaceuticals, For: Apr 23 | SEC filing · Form DEF | +0.95% | -2.45% | |
| Form DEFA14A Apellis Pharmaceuticals, | SEC filing · Form DEFA14A | +0.95% | -2.45% | |
| Form 8-K Apellis Pharmaceuticals, For: Apr 17 | SEC filing · Form 8-K | -1.03% | +0.17% | |
| Form 10-K Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.64% | -3.19% | |
| Form S-8 Apellis Pharmaceuticals, | SEC filing · Form S-8 | -4.64% | -3.19% | |
| Form 8-K Apellis Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | -1.08% | +0.04% | |
| Form 10-Q Apellis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.42% | +10.53% | |
| Form 8-K Apellis Pharmaceuticals, For: Aug 08 | SEC filing · Form 8-K | -5.18% | +3.18% | |
| Form 10-Q Apellis Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.32% | -5.26% | |
| Form 8-K Apellis Pharmaceuticals, For: Jun 05 | SEC filing · Form 8-K | -1.07% | -1.44% | |
| Form 8-K Apellis Pharmaceuticals, For: May 13 | SEC filing · Form 8-K | +1.12% | -4.21% | |
| Form 10-Q Apellis Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +4.41% | -2.66% | |
| Form ARS Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | -0.57% | -2.33% | |
| Form DEF 14A Apellis Pharmaceuticals, For: Apr 26 | SEC filing · Form DEF | -0.57% | -2.33% | |
| Form DEFA14A Apellis Pharmaceuticals, | SEC filing · Form DEFA14A | -0.57% | -2.33% | |
| Form 10-K/A Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.23% | +1.64% | |
| Form 10-K Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.60% | -0.30% | |
| Form 8-K Apellis Pharmaceuticals, For: Feb 27 | SEC filing · Form 8-K | +0.60% | -0.30% | |
| Form S-8 Apellis Pharmaceuticals, | SEC filing · Form S-8 | +0.60% | -0.30% | |
| Form 8-K Apellis Pharmaceuticals, For: Jan 16 | SEC filing · Form 8-K | +0.75% | +2.20% | |
| Form 8-K Apellis Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | +0.61% | +15.14% | |
| Form 8-K Apellis Pharmaceuticals, For: Dec 14 | SEC filing · Form 8-K | -2.23% | -2.05% | |
| Form 8-K Apellis Pharmaceuticals, For: Nov 30 | SEC filing · Form 8-K | +0.49% | +14.06% | |
| Form 10-Q Apellis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +5.38% | +8.29% | |
| Form 8-K Apellis Pharmaceuticals, For: Oct 31 | SEC filing · Form 8-K | +5.38% | +8.29% |
Keep exploring
More APLS: earnings → · analyst actions → · APLS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ESSA Pharma Inc. (EPIX) | 718 | 0.00% | 38% |
| Tricida, Inc. (TCDA) | 715 | +0.06% | 51% |
| Enochian Biosciences, Inc. (ENOB) | 712 | 0.00% | 42% |
| LIFEPOINT HEALTH INC COMMON (LPNT) | 709 | +0.01% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.